Human retinal pigment epithelial cell transplantation for the treatment of Parkinson's disease
Cell replacement therapies have been thoroughly investigated in the hope of finding a long-term, continuous dopaminergic (DAergic) source to treat motor dysfunctions in Parkinson’s disease (PD). However, mixed clinical results, safety and logistical concerns, and ethical issues have led to the inter...
Main Author: | |
---|---|
Language: | English |
Published: |
University of British Columbia
2011
|
Online Access: | http://hdl.handle.net/2429/36675 |
Search Result 1
Search Result 2